BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 14647064)

  • 1. Polyunsaturated fatty acids ameliorate hepatic steatosis in obese mice by SREBP-1 suppression.
    Sekiya M; Yahagi N; Matsuzaka T; Najima Y; Nakakuki M; Nagai R; Ishibashi S; Osuga J; Yamada N; Shimano H
    Hepatology; 2003 Dec; 38(6):1529-39. PubMed ID: 14647064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice.
    Dentin R; Benhamed F; Hainault I; Fauveau V; Foufelle F; Dyck JR; Girard J; Postic C
    Diabetes; 2006 Aug; 55(8):2159-70. PubMed ID: 16873678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Molecular mechanisms of action and health benefits of polyunsaturated fatty acids].
    Rodríguez-Cruz M; Tovar AR; del Prado M; Torres N
    Rev Invest Clin; 2005; 57(3):457-72. PubMed ID: 16187707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver-specific disruption of PPARgamma in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypes.
    Matsusue K; Haluzik M; Lambert G; Yim SH; Gavrilova O; Ward JM; Brewer B; Reitman ML; Gonzalez FJ
    J Clin Invest; 2003 Mar; 111(5):737-47. PubMed ID: 12618528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
    Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
    Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peroxisome-proliferator-activated receptor-alpha (PPARalpha) deficiency leads to dysregulation of hepatic lipid and carbohydrate metabolism by fatty acids and insulin.
    Sugden MC; Bulmer K; Gibbons GF; Knight BL; Holness MJ
    Biochem J; 2002 Jun; 364(Pt 2):361-8. PubMed ID: 12023878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential induction of genes in liver and brown adipose tissue regulated by peroxisome proliferator-activated receptor-alpha during fasting and cold exposure in acyl-CoA dehydrogenase-deficient mice.
    Goetzman ES; Tian L; Wood PA
    Mol Genet Metab; 2005 Jan; 84(1):39-47. PubMed ID: 15639194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do polyunsaturated fatty acids ameliorate hepatic steatosis in obese mice by SREPB-1 suppression or by correcting essential fatty acid deficiency.
    Alwayn IP; Javid PJ; Gura KM; Nosé V; Ollero M; Puder M
    Hepatology; 2004 Apr; 39(4):1176-7; author reply 1177-8. PubMed ID: 15057926
    [No Abstract]   [Full Text] [Related]  

  • 9. Cloning and characterization of the human stearoyl-CoA desaturase gene promoter: transcriptional activation by sterol regulatory element binding protein and repression by polyunsaturated fatty acids and cholesterol.
    Bené H; Lasky D; Ntambi JM
    Biochem Biophys Res Commun; 2001 Jun; 284(5):1194-8. PubMed ID: 11414710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dietary docosahexaenoic acid-rich diacylglycerols ameliorate hepatic steatosis and alter hepatic gene expressions in C57BL/6J-Lep(ob/ob) mice.
    Kim HJ; Lee KT; Park YB; Jeon SM; Choi MS
    Mol Nutr Food Res; 2008 Aug; 52(8):965-73. PubMed ID: 18481331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered expression of transcription factors and genes regulating lipogenesis in liver and adipose tissue of mice with high fat diet-induced obesity and nonalcoholic fatty liver disease.
    Morgan K; Uyuni A; Nandgiri G; Mao L; Castaneda L; Kathirvel E; French SW; Morgan TR
    Eur J Gastroenterol Hepatol; 2008 Sep; 20(9):843-54. PubMed ID: 18794597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin 6 alleviates hepatic steatosis and ischemia/reperfusion injury in mice with fatty liver disease.
    Hong F; Radaeva S; Pan HN; Tian Z; Veech R; Gao B
    Hepatology; 2004 Oct; 40(4):933-41. PubMed ID: 15382116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Green tea extract attenuates hepatic steatosis by decreasing adipose lipogenesis and enhancing hepatic antioxidant defenses in ob/ob mice.
    Park HJ; DiNatale DA; Chung MY; Park YK; Lee JY; Koo SI; O'Connor M; Manautou JE; Bruno RS
    J Nutr Biochem; 2011 Apr; 22(4):393-400. PubMed ID: 20655714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leptin suppresses stearoyl-CoA desaturase 1 by mechanisms independent of insulin and sterol regulatory element-binding protein-1c.
    Biddinger SB; Miyazaki M; Boucher J; Ntambi JM; Kahn CR
    Diabetes; 2006 Jul; 55(7):2032-41. PubMed ID: 16804073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TNF-alpha induces hepatic steatosis in mice by enhancing gene expression of sterol regulatory element binding protein-1c (SREBP-1c).
    Endo M; Masaki T; Seike M; Yoshimatsu H
    Exp Biol Med (Maywood); 2007 May; 232(5):614-21. PubMed ID: 17463157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of peroxisome proliferator-activated receptor alpha by dietary fish oil attenuates steatosis, but does not prevent experimental steatohepatitis because of hepatic lipoperoxide accumulation.
    Larter CZ; Yeh MM; Cheng J; Williams J; Brown S; dela Pena A; Bell-Anderson KS; Farrell GC
    J Gastroenterol Hepatol; 2008 Feb; 23(2):267-75. PubMed ID: 17868330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dietary cholesterol opposes PUFA-mediated repression of the stearoyl-CoA desaturase-1 gene by SREBP-1 independent mechanism.
    Kim HJ; Miyazaki M; Ntambi JM
    J Lipid Res; 2002 Oct; 43(10):1750-7. PubMed ID: 12364560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of insulin signaling through inhibition of tissue lipid accumulation by activation of peroxisome proliferator-activated receptor (PPAR) alpha in obese mice.
    Ide T; Tsunoda M; Mochizuki T; Murakami K
    Med Sci Monit; 2004 Oct; 10(10):BR388-95. PubMed ID: 15448592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bovine growth hormone-transgenic mice have major alterations in hepatic expression of metabolic genes.
    Olsson B; Bohlooly-Y M; Brusehed O; Isaksson OG; Ahrén B; Olofsson SO; Oscarsson J; Törnell J
    Am J Physiol Endocrinol Metab; 2003 Sep; 285(3):E504-11. PubMed ID: 12736163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A role for PPARalpha in the control of SREBP activity and lipid synthesis in the liver.
    Knight BL; Hebbachi A; Hauton D; Brown AM; Wiggins D; Patel DD; Gibbons GF
    Biochem J; 2005 Jul; 389(Pt 2):413-21. PubMed ID: 15777286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.